Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

Yoshinobu Onuma, PWJC (Patrick) Serruys, JA Ormiston, Evelyn Regar, M Webster, L Thuesen, D Dudek, S Veldhof, R Rapoza

Research output: Contribution to journalArticleAcademicpeer-review

115 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)447-453
Number of pages7
JournalEuroIntervention
Volume6
Issue number4
Publication statusPublished - 2010

Cite this